{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:26:19Z","timestamp":1786123579005,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bone.2026.117996","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T21:58:47Z","timestamp":1782683927000},"page":"117996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-909X","authenticated-orcid":false,"given":"Priya S.","family":"Kishnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-6723","authenticated-orcid":false,"given":"Steven","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-5626","authenticated-orcid":false,"given":"Julie","family":"Hoover-Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-9626","authenticated-orcid":false,"given":"J. Carl","family":"Pallais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Voskopoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7019-5647","authenticated-orcid":false,"given":"Shona","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Mowrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8147-7315","authenticated-orcid":false,"given":"Eric","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-9138","authenticated-orcid":false,"given":"Kathryn","family":"Dahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2026.117996_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2026.117996_bb0010","doi-asserted-by":"crossref","DOI":"10.20945\/2359-3997000000626","article-title":"Hypophosphatasia: from birth to adulthood","volume":"67","author":"Reis","year":"2023","journal-title":"Arch. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-024-03048-6","article-title":"Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry","volume":"19","author":"Kishnani","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2026.117996_bb0020","first-page":"380","article-title":"Hypophosphatasia","volume":"10","author":"Rockman-Greenberg","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2056","article-title":"Not just a carrier: clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening","volume":"11","author":"Beck","year":"2023","journal-title":"Mol. Genet. Genomic Med."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12891-019-2420-8","article-title":"Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry","volume":"20","author":"H\u00f6gler","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.bone.2026.117996_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","article-title":"Neurological symptoms in hypophosphatasia","volume":"30","author":"Colazo","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2026.117996_bb0040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s40618-023-02256-4","article-title":"A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States","volume":"47","author":"Dahir","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bone.2026.117996_bb0055","author":"Prospective"},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13023-022-02572-7","article-title":"Identifying adult hypophosphatasia in the rheumatology unit","volume":"17","author":"Feurstein","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.bone.2026.117996_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10395","article-title":"Physical function and health-related quality of life in adults treated with asfotase alfa for pediatric-onset hypophosphatasia","volume":"4","author":"Genest","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2026.117996_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117996_bb0075","series-title":"Strensiq [package insert]","author":"Pharmaceuticals","year":"2024"},{"issue":"10","key":"10.1016\/j.bone.2026.117996_bb0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/jbmr\/zjae128","article-title":"Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia","volume":"39","author":"Dahir","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117996_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1138599","article-title":"Impact of muscular symptoms and\/or pain on disease characteristics, disability, and quality of life in adult patients with hypophosphatasia: a cross-sectional analysis from the Global HPP Registry","volume":"14","author":"Dahir","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2026.117996_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10131","article-title":"Reliability and validity of the 6-minute walk test in hypophosphatasia","volume":"3","author":"Phillips","year":"2019","journal-title":"JBMR Plus."},{"key":"10.1016\/j.bone.2026.117996_bb0095","series-title":"The Brief Pain Inventory User Guide","author":"Cleeland","year":"2009"},{"issue":"6","key":"10.1016\/j.bone.2026.117996_bb0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"issue":"24","key":"10.1016\/j.bone.2026.117996_bb0110","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 Health Survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine (Phila. Pa. 1986)"},{"issue":"11","key":"10.1016\/j.bone.2026.117996_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63781","article-title":"New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry","volume":"194","author":"Kishnani","year":"2024","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.bone.2026.117996_bb0120","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5\u2032-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004","volume":"87","author":"Morris","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bone.2026.117996_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116504","article-title":"Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults","volume":"163","author":"Shajani-Yi","year":"2022","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2026.117996_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejr.2017.09.007","article-title":"Quality of life in fibromyalgia, osteoarthritis and rheumatoid arthritis patients: Comparison of different scales","volume":"40","author":"Atao\u011flu","year":"2018","journal-title":"Egypt. Rheumatol."},{"issue":"8","key":"10.1016\/j.bone.2026.117996_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4187\/respcare.03480783","article-title":"The six-minute walk test","volume":"48","author":"Enright","year":"2003","journal-title":"Respir. Care"},{"issue":"5 Pt 1","key":"10.1016\/j.bone.2026.117996_bb0140","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","article-title":"Reference equations for the six-minute walk in healthy adults","volume":"158","author":"Enright","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.bone.2026.117996_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70083","article-title":"Revisiting the genetics of hypophosphatasia","volume":"48","author":"Kishnani","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.bone.2026.117996_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","article-title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","volume":"35","author":"Khan","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-023-06843-2","article-title":"Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group","volume":"35","author":"Rush","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2026.117996_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00198-023-06859-8","article-title":"The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance","volume":"35","author":"Brandi","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2026.117996_bb0165","first-page":"38","article-title":"A case of hypophosphatasia with normal alkaline phosphatase levels","volume":"10","author":"Dattagupta","year":"2024","journal-title":"AACE Clin. Case Rep."},{"issue":"11","key":"10.1016\/j.bone.2026.117996_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2023.104866","article-title":"Serum alkaline phosphatase can be elevated in patients with hypophosphatasia due to liver disease","volume":"66","author":"van Velsen","year":"2023","journal-title":"Eur. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0175","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/s13023-025-04129-w","article-title":"The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data","volume":"20","author":"Kishnani","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bone.2026.117996_bb0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.77.4","article-title":"The mechanism of mineralization and the role of alkaline phosphatase in health and disease","volume":"77","author":"Orimo","year":"2010","journal-title":"J. Nippon Med. Sch."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822600222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822600222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:42:41Z","timestamp":1786117361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822600222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S875632822600222X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117996","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117996"}}